Analysis of IL-10 and IL-35 in dipeptidyl peptidase-4 inhibitor-related bullous pemphigoid.

Kokubu, Hiraku; Takahashi, Toshifumi; Kabuto, Miho; Kouzaki, Hideaki; Fujimoto, Noriki

Kokubu, Hiraku; Takahashi, Toshifumi; Kabuto, Miho; Kouzaki, Hideaki; Fujimoto, Noriki.

Afiliação

Kokubu H; Department of Dermatology, Shiga University of Medical Science, Otsu, Japan.
Takahashi T; Department of Dermatology, Shiga University of Medical Science, Otsu, Japan.
Kabuto M; Department of Dermatology, Shiga University of Medical Science, Otsu, Japan.
Kouzaki H; Department of Otolaryngology-Head and Neck Surgery, Shiga University of Medical Science, Otsu, Japan.
Fujimoto N; Department of Dermatology, Shiga University of Medical Science, Otsu, Japan.

Exp Dermatol ; 32(9): 1569-1574, 2023 09.

Article em En | MEDLINE | ID: mdl-37424368

Assuntos

Diabetes Mellitus Tipo 2; Inibidores da Dipeptidil Peptidase IV; Penfigoide Bolhoso; Masculino; Feminino; Humanos; Inibidores da Dipeptidil Peptidase IV/efeitos adversos; Dipeptidil Peptidase 4; Interleucina-10; Hipoglicemiantes

Palavras-chave

CD26; DPP-4 inhibitor; IL-35; L-10; bullous pemphigoid

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Penfigoide Bolhoso / Diabetes Mellitus Tipo 2 / Inibidores da Dipeptidil Peptidase IV Limite: Female / Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google